Browse studies

Find your next paid study

27,370 recruiting studies available now

Newest first Highest paying

Parkinson's Foundation PD GENEration Genetic Registry

Development of a central repository for PD-related genomic data for future research.

Parkinson's Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

Parkinson's FoundationNCT04994015

Phase 1

Lidocaine Infusion in Pancreatic Cancer: Translational Studies in a Preclinical Model And Human Subjects

This study elucidates the effects of the intravenous (IV) lidocaine infusion on the biology of pancreatic circulating tumor cells (CTCs) isolated from patients…

Pancreatic Cancer

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Illinois at ChicagoNCT04048278

Phase 1

A Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-21447 (a Bcl-2 Inhibitor) Combinations for Patients With HR+/HER2- Metastatic Breast Cancer

This is a dose escalation and dose expansion study to assess the safety and tolerability of BGB-21447 (a B-cell leukemia/lymphoma 2 inhibitor, Bcl-2i) in combi…

Hormone-receptor-positive Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BeOne MedicinesNCT06756932

Observational

Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation

Primary PC - or training HCT clinicians to deliver PC domains as part of routine practice - is an alternative model of supportive care. We have developed Senti…

Hematopoietic Cell TransplantHematologic Malignancy

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT06676852

Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I)

A prospective, multicenter, observational study to evaluate the correlation of Molecular Residual Disease (MRD) detection using circulating tumor DNA guided te…

TNBC - Triple-Negative Breast CancerMinimal Residual Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Personalis Inc.NCT06230185

Phase 2

Immuno-consolidation for Newly Diagnosed Multiple Myeloma Using Lack of MRD Negativity After Initial cOmbination Therapy to Pursue Deeper Responses With Linvoseltamab ANd Delay Transplant

The purpose of this study is to determine whether Linvoseltamab therapy in patients with newly diagnosed multiple myeloma will convert the disease status from …

Multiple Myeloma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Dickran Kazandjian, MDNCT06376526

Phase 1

PRISM: Phase 1b of Retifanlimab and Ruxolitinib In Solid Malignancies Progressing on Prior Checkpoint Inhibition

The goal of this clinical trial is to learn what dose of ruxolitinib can be given safely together with retifanlimab in patients with metastatic renal cell carc…

Non Small Cell Lung CarcinomaRenal Cell Carcinoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of California, San DiegoNCT07219576

Observational

Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Trained Human Sensory Panels

Many people, particularly small children, must take drugs in liquid form because they cannot swallow pills or capsules. The bad taste of some liquid drugs can …

Healthy Adults

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Monell Chemical Senses CenterNCT06929455

Phase 1

Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

Rates of bacterial sexually transmitted infections (STIs) are rising globally, demanding innovative interventions beyond the scope of current efforts to preven…

Sexually Transmitted Diseases, Bacterial

Estimated

~$500 – $6,750

Actual pay is set by the research site.

University of California, San FranciscoNCT06414408

Phase 2

A Phase 2, Randomized, Double-blind, Placebo-controlled Pilot Study Assessing the Efficacy, Safety and Tolerability of Orally Administered BMS-986368, a FAAH/MAGL Inhibitor, for the Treatment of Spasticity in Participants With Post-stroke Spasticity

The goal of this clinical trial is to learn if the drug BMS-986368 works to treat post stroke spasticity in adults who have had a stroke. BMS-986368 is a desig…

Post-Stroke Spasticity

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Alberto EsquenaziNCT07704840

Phase 3

Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in Youth: A Randomized Clinical Trial

This is a Phase 3a, randomized, parallel-controlled trial designed to compare the early re-initiation of semaglutide, starting two weeks after sleeve gastrecto…

Pediatric ObesityMetabolic and Bariatric SurgerySemaglutide

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Children's Hospital Los AngelesNCT06934655

Phase 3

A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF 3 LOTS OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS

The purpose of this study is to provide safety data and demonstrate lot consistency with the PG4 vaccine by evaluating the immunogenicity of 3 different lots o…

Pneumococcal Disease

Estimated

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT07794748